Cubist Pharmaceuticals (CBST) Tops Q3 EPS Views
CBST Hot Sheet
EPS Growth %: -18.2%Financial Fact:
Basic net (loss) income per common share (in shares): 63M
Today's EPS Names:
VSNT, CIM, KH, More
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reports Q3 EPS of $0.42, or $0.65 non-GAAP, 9 better than the analyst estimate of $0.33. Revenue rose 28% to $143.5 million, which compares to the estimate of $142.12 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
